RARE vs. SANA
Compare and contrast key facts about Ultragenyx Pharmaceutical Inc. (RARE) and Sana Biotechnology, Inc. (SANA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RARE or SANA.
Correlation
The correlation between RARE and SANA is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
RARE vs. SANA - Performance Comparison
Key characteristics
RARE:
-0.27
SANA:
-0.34
RARE:
-0.12
SANA:
0.09
RARE:
0.99
SANA:
1.01
RARE:
-0.14
SANA:
-0.65
RARE:
-0.59
SANA:
-1.13
RARE:
18.54%
SANA:
55.80%
RARE:
40.90%
SANA:
184.47%
RARE:
-82.11%
SANA:
-96.32%
RARE:
-75.99%
SANA:
-93.08%
Fundamentals
RARE:
$3.94B
SANA:
$672.04M
RARE:
-$6.29
SANA:
-$1.40
RARE:
$560.23M
SANA:
$0.00
RARE:
$465.80M
SANA:
-$7.64M
RARE:
-$360.20M
SANA:
-$207.59M
Returns By Period
In the year-to-date period, RARE achieves a 1.24% return, which is significantly lower than SANA's 84.66% return.
RARE
1.24%
-5.04%
-24.95%
-13.92%
-5.69%
-2.66%
SANA
84.66%
-13.75%
-48.46%
-63.67%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RARE vs. SANA — Risk-Adjusted Performance Rank
RARE
SANA
RARE vs. SANA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Ultragenyx Pharmaceutical Inc. (RARE) and Sana Biotechnology, Inc. (SANA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RARE vs. SANA - Dividend Comparison
Neither RARE nor SANA has paid dividends to shareholders.
Drawdowns
RARE vs. SANA - Drawdown Comparison
The maximum RARE drawdown since its inception was -82.11%, smaller than the maximum SANA drawdown of -96.32%. Use the drawdown chart below to compare losses from any high point for RARE and SANA. For additional features, visit the drawdowns tool.
Volatility
RARE vs. SANA - Volatility Comparison
The current volatility for Ultragenyx Pharmaceutical Inc. (RARE) is 9.71%, while Sana Biotechnology, Inc. (SANA) has a volatility of 23.71%. This indicates that RARE experiences smaller price fluctuations and is considered to be less risky than SANA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RARE vs. SANA - Financials Comparison
This section allows you to compare key financial metrics between Ultragenyx Pharmaceutical Inc. and Sana Biotechnology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities